Bacterial target proteins

Bacterial target proteins represent the specific molecular sites within bacteria that are targeted by antimicrobial agents to inhibit growth or cause cell death (StatPearls, 2023). These targets are categorized based on the essential biological processes they govern, such as cell wall biosynthesis, protein synthesis, and nucleic acid metabolism (NIH, 2022). For instance, beta-lactam antibiotics target penicillin-binding proteins (PBPs) to disrupt the integrity of the bacterial cell wall, while macrolides and aminoglycosides bind to ribosomal subunits to halt protein production (PubMed, 2021). Other critical targets include DNA gyrase and topoisomerase IV, which are essential for DNA replication and are inhibited by fluoroquinolones. Because these proteins are often distinct from human homologs, they provide a basis for selective toxicity, though the rapid evolution of these targets frequently leads to antimicrobial resistance (WHO, 2023). Understanding the structural and functional nuances of these proteins is vital for the design of novel drugs capable of bypassing existing resistance mechanisms.

Other names

Antibiotic targetsProkaryotic drug targetsBacterial enzymesBacterial protein targets

Bacterial target proteins are inhibited through various mechanisms including the disruption of peptidoglycan cross-linking, binding to ribosomal subunits to inhibit translation, and inhibition of enzymes like DNA gyrase to prevent replication.